We extracted the following 30 factors: age, sex, body mass index (BMI), race (Asian, American Indian or Alaska Native, Black or African American, Native Hawaiian or Other Pacific Islander, White, Other Race, unknown), diagnoses (heart failure, ischemic heart diseases, old myocardial infarction, atrial fibrillation and flutter, hypertension, dyslipidemia, chronic kidney disease, cerebral infarction), and medication (be-ta blockers, diuretics, mineralocorticoid receptor antagonists [MRA], angiotensin converting enzyme [ACE] inhibitors, angiotensin II receptor blockers [ARB], sacubitril, statins, metformin, sulfonylureas, sodium-glucose co-transporter 2 [SGLT2] inhibitors, insulin, laboratory (systolic blood pressure, diastolic blood pressure, glomerular filtration rate [GFR], hemoglobin, albumin, LDL cholesterol, hemoglobin A1c [HbA1c])
In these cases, artificial tears, punctal plugs, or prescription eye drops to increase tear production may be used
Toxins 11:523
La era de los medicamentos GLP-1 apenas comienza, y con ella viene la necesidad de replantear como sociedad y medicina entienden y abordan la obesidad: no como una cuestin de fuerza de voluntad, sino como una condicin mdica compleja que, como tantas otras, puede requerir tratamiento sostenido para su manejo efectivo
